<br><br><div class="gmail_quote">---------- Forwarded message ----------<br>From: <b class="gmail_sendername">Jean-Francois P Hamel</b> <span dir="ltr"><<a href="mailto:jhamel@mit.edu">jhamel@mit.edu</a>></span><br><br>
<br>
<br>
Dear Seniors,<br>
<br>
Just a few more days before graduation, and I imagine you are busy, excited and<br>
looking forward to the new chapter in your life.<br>
<br>
If you are still looking for a position, and are interested in the analytical<br>
area of biological engineering, there is a position -not yet formally<br>
advertised- at a South San Franciso Company, which is part of Pfizer. One of my<br>
former UROP students has alerted me to it. I am planning to visit her in early<br>
June.<br>
<br>
The informal job description is below. If you are interested in this<br>
opportunity, please let me know and send me a copy of your resume (at<br>
<a href="mailto:jhamel@mit.edu">jhamel@mit.edu</a>). I will then introduce you.<br>
<br>
The new hire would be learning kinetics, high-throughput screening, epitope<br>
binning and other protein-protein interaction techniques on real-time<br>
biosensors such as the Biacore 2000 and 3000 (Surface Plasmon Resonance devices<br>
with 4 flow cells), the Bio-Rad's ProteOn (another SPR device 6x6 flowcell<br>
matrix with 36 biosensor spots and reference interspots), and ForteBio's Octet<br>
Red and QK384 (Bio-Layer Interferometry devices).<br>
<br>
The South San Francisco Pfizer site, also known as "Rinat," is a drug discovery<br>
site of approximately 90 people that focuses on monoclonal antibody<br>
therapeutics in a variety of diseases and conditions. Originally a small<br>
independent biotech company, it was purchased by Pfizer in 2006 for its drug<br>
candidates as well as its extensive pipeline built in a short period of time.<br>
Currently, 4 drugs from Rinat are in clinical trials with others on the way.<br>
<br>
The biosensor team is part of the Protein Engineering group at Rinat and<br>
consists of 3 members, with the team leader coming from David Myskza's lab at<br>
the University of Utah, generally recognized as the most renowned Biacore and<br>
biosensor lab in the field. Projects are requested by other drug discovery<br>
scientists, at which point the team will discuss their needs and propose<br>
experiments that will properly analyze their samples. Results have a huge and<br>
immediate impact on the site's ongoing science at all stages of discovery.<br>
Additionally, because of the wide variety of targets available and experiments<br>
requested, novel assay design is a constant necessity which often leads to<br>
published papers.<br>
<br>
Yours,<br>
<br>
J.-F. Hamel<br>
</div><br>